|
|
Дата |
|---|
| 26.10.2026 |
| 25.10.2026 |
| 22.10.2026 |
| 21.10.2026 |
| 20.10.2026 |
| 19.10.2026 |
| 18.10.2026 |
| 15.10.2026 |
| 14.10.2026 |
| 13.10.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
94.20
|
90.20
|
96.97
|
93.10
|
|
|
61 996 530.30
|
2 915.00
|
|
|
|
101.90
|
91.61
|
101.90
|
94.20
|
|
|
46 414 950.59
|
2 377.00
|
|
|
|
103.35
|
100.00
|
103.60
|
101.90
|
|
|
36 492 331.33
|
1 835.00
|
|
|
|
104.39
|
103.02
|
106.88
|
103.35
|
|
|
32 778 152.29
|
1 573.00
|
|
|
|
104.50
|
104.00
|
105.90
|
104.39
|
|
|
25 796 444.19
|
1 148.00
|
|
|
|
101.50
|
98.05
|
106.10
|
104.50
|
|
|
84 067 246.06
|
2 909.00
|
|
|
|
107.60
|
101.50
|
107.60
|
101.50
|
|
|
36 643 130.79
|
2 090.00
|
|
|
|
107.24
|
105.50
|
109.00
|
107.60
|
|
|
21 218 842.55
|
950.00
|
|
|
|
105.50
|
105.50
|
109.19
|
107.24
|
|
|
30 670 174.39
|
1 122.00
|
|
|
|
107.71
|
102.00
|
109.89
|
105.50
|
|
|
54 286 913.91
|
2 380.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
